News

AAIC 2020, dallo studio DIAN-TU la terapia contro l’Alzheimer

affaritaliani.it, 31 luglio 2020

Elixir Factor Podcast S2 Ep6: Dominantly Inherited Alzheimer’s Disease: A View From Within

Lilly

Gantenerumab improved markers of disease in rare, inherited form of Alzheimer’s disease

Further analysis of data from an international trial of two investigational drugs in people in the early stages of a...

In DIAN-TU, Gantenerumab Brings Down Tau. By a Lot. Open Extension Planned

Alzforum - Apr 10, 2020

Confused About the DIAN-TU Trial Data? Experts Discuss Nuances

Alzforum - Apr 10, 2020

Topline Result for First DIAN-TU Clinical Trial: Negative on Primary

Alzforum - Feb 10 2020

Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - FEB 10 2020

DIAN-TU Mcdade: “Nel 2020 sapremo se possiamo bloccare l’Alzheimer”

affaritaliani.it, 23 dicembre 2019

Importante estudio en enfermedad de Alzheimer abrirá 5 nuevos sitios latinoamericanos

Washington University School of Medicine news release - Nov 20 2019

Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease

New York Times - Nov 4 2019